Are you Dr. Glasberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
28001 Smyth Dr
#108
Valencia, CA 91355Phone+1 661-702-9211Fax+1 661-702-9255
Summary
- Dr. Mark Glasberg, MD is a board certified neurologist in Valencia, California. He is currently licensed to practice medicine in California, Ohio, and Arizona. He is affiliated with Henry Mayo Newhall Hospital, Olive View-UCLA Medical Center, and Valley Presbyterian Hospital.
Education & Training
- Armed Forces Institute of PathologyFellowship, Neuropathology, 1975 - 1976
- University of California (San Diego) Medical CenterResidency, Neurology, 1971 - 1974
- MedStar Health/Georgetown University HospitalResidency, Pathology-Anatomic and Clinical, 1970 - 1971
- University of California (San Francisco)Residency, Surgery, 1969 - 1970
- Abington Memorial HospitalInternship, Transitional Year, 1968 - 1969
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1968
Certifications & Licensure
- CA State Medical License 1969 - 2025
- AZ State Medical License 1983 - 2024
- OH State Medical License 1990 - 2003
- MI State Medical License 1983 - 1993
- TX State Medical License 1979 - 1988
- American Board of Pathology Neuropathology
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 67 citationsPeripheral Neuropathy and Starvation After Gastric Partitioning for Morbid ObesityHoward Feit, Mark Glasberg, Carol S. Ireton, Roger N. Rosenberg, Erwin Thal
Annals of Internal Medicine. 1982-04-01 - 6 citationsHypercapnic respiratory failure due to L-tryptophan-induced eosinophilic polymyositis.Mark J. Ivey, Michael S. Eichenhorn, Mark R. Glasberg, Robert C. Hyzy
Chest. 1991-03-01 - 93 citationsNeurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studiesEdward A. Neuwelt, Mark Glasberg, E. P. Frenkel, Peggy A. Barnett
Annals of Neurology. 1983-09-01